# Oncobox

Source: https://onco.cc/companies/oncobox/  
OnCo record `oncobox` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Oncobox profiles a tumour's genes and the activity of its signalling pathways, then ranks approved targeted drugs by how likely they are to work for that patient.

## Summary

Oncobox Dx combines tumour DNA and RNA sequencing with pathway-activation algorithms to score more than a hundred marketed targeted drugs for an individual patient with advanced cancer, returning a ranked report for the treating oncologist. Its YC profile cites a European and Asian study of about 900 late-stage patients in which the approach was associated with higher targeted-therapy effectiveness; that work is observational and the test has not been validated in a randomised trial. Oncobox remains active in the YC directory and markets to clinicians, hospitals and pharma.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: yc
- HQ: Walnut, CA
- Type: diagnostics
- Website: https://oncobox.com

## Sources

- Y Combinator profile: https://www.ycombinator.com/companies/oncobox
- Official website: https://oncobox.com

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Targeted Therapy](https://onco.cc/fronts/targeted-therapy/)
- technologies: [Comprehensive genomic profiling](https://onco.cc/technologies/cgp/), [RNA sequencing & expression profiling](https://onco.cc/technologies/rna-seq/)
- companies: [Y Combinator](https://onco.cc/companies/y-combinator/)

---
JSON: https://onco.cc/api/v1/entities/oncobox.json